Recombinant Bovine Cathelicidin-4 Protein，His & SUMO

Cathelicidin-4 (CATH-4) is a member of the cathelicidin family of antimicrobial peptides, which play a crucial role in the innate immune response of various organisms. Initially discovered in specific vertebrates, such as humans and mice, CATH-4 is known for its potent antimicrobial properties against a wide range of pathogens, including bacteria, viruses, and fungi. Its mechanism of action involves disrupting microbial membranes, leading to cell lysis. Research into CATH-4 is particularly relevant due to the increasing prevalence of antibiotic-resistant infections, making the development of new antimicrobial agents imperative. Furthermore, CATH-4 exhibits additional functions, including immunomodulatory effects, promoting wound healing and modulating inflammatory responses. Studies have shown that this peptide can enhance the activity of other immune cells, thus contributing to a more comprehensive approach to infection control. Additionally, recombinant technology has enabled the production of CATH-4 in vitro, facilitating detailed studies on its structure-function relationship and therapeutic potential. Investigating CATH-4 not only contributes to the fundamental understanding of innate immunity but also opens avenues for the development of novel therapeutics in combating resistant microbial strains and improving clinical outcomes in infectious diseases. As such, CATH-4 represents a promising candidate in the search for effective antimicrobial therapies and serves as a critical focus for further research in immunology and infectious disease management.